0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Rescue percutaneous mitral balloon valvuloplasty for iatrogenic critical mitral stenosis after open mitral valve repair for rheumatic mitral regurgitation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mitral valve repair is a feasible option in rheumatic heart disease with reasonable long-term results. 1 , 2 Early mitral stenosis is a very rare complication of mitral valve repair. Percutaneous balloon mitral valvuloplasty (PBMV) can serve as a bailout procedure if reoperation is a very high risk. Here, we report a patient who underwent successful PBMV due to iatrogenic critical mitral stenosis. A 14-year-old Asian male underwent mitral valve repair after he presented with exertional dyspnoea (New York Heart Association Class II/III). He was a known case of severe rheumatic mitral regurgitation for 7 years. His transoesophageal echocardiography (TOE) showed mildly thickened leaflets and flail P3 scallop (Carpentier type II and IIIa) (Supplementary material online, Video S1). The valve was repaired using the annuloplasty Physio ring (32 mm), new chord to the anterior mitral leaflet, and plication of both commissures. There was no residual mitral regurgitation on intraoperative echocardiogram, but a higher mean gradient (5 mmHg). The next day, he was extubated but reintubated again due to signs of acute pulmonary oedema, desaturation, and significant hypotension. Echocardiography showed significant diastolic flow acceleration across the repaired mitral valve with a mean gradient of 19 mmHg (heart rate 134 b.p.m.) and the mitral valve area (MVA) of 0.42 cm2 (measured by 3D TOE) and both commissures were fused ( Figure 1 , Supplementary material online, Video S2, Image S1). The patient was at high risk for redo surgery due to significant hypotension (89/54 mm/Hg) despite ionotropic support, so the next morning, he underwent PBMV. Multiple balloon inflations ( Figure 2 ) were done using Inoue-Balloon, which resulted in a significant increase in MVA up to 1.5 cm2 with open commissures and the mean gradient dropped to 5 mmHg (Supplementary material online, Videos S3–S5). There was only mild mitral regurgitation which gradually regressed on follow-up. Percutaneous mitral balloon valvotomy can be considered for iatrogenic mitral stenosis after mitral valve repair. Figure 1 Three-dimensional transoesophageal echocardiography showing severe mitral stenosis with a mitral valve area of 0.42 cm2 and commissural fusion (arrowheads). Annuloplasty ring can also be seen (white arrow). Figure 2 Two-dimensional transoesophageal echocardiography showing inflated Inoue-Balloon (white arrow) in the repaired mitral valve using an annuloplasty ring (arrowheads). Supplementary material Supplementary material is available at European Heart Journal - Case Reports online. Consent: The author/s confirm that written consent for submission and publication of this case report including image(s) and associated text has been obtained from the patient in line with COPE guidance. Conflict of interest: none declared. Supplementary Material ytaa345_Supplementary_Data Click here for additional data file.

          Related collections

          Most cited references2

          • Record: found
          • Abstract: found
          • Article: not found

          Outcomes after mitral valve surgery for rheumatic heart disease.

          To further the understanding of the factors influencing outcome following rheumatic heart disease (RHD) related mitral valve surgery, which globally remains an important cause of heart disease and a particular problem in Indigenous Australians.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Long-Term Results of Mitral Valve Repair

            Introduction Current guidelines state that patients with severe mitral regurgitation should be treated in reference centers with a high reparability rate, low mortality rate, and durable results. Objective To analyze our global experience with the treatment of organic mitral regurgitation from various etiologies operated in a single center. Methods We evaluated all surgically treated patients with organic mitral regurgitation from 2004-2017. Patients were evaluated clinically and by echocardiography every year. We determined early and late survival rates, valve related events and freedom from recurrent mitral regurgitation and tricuspid regurgitation. Valve failure was defined as any mitral regurgitation ≥ moderate degree or the need for reoperation for any reason. Results Out of 133 patients with organic mitral regurgitation, 125 (93.9%) were submitted to valve repair. Mean age was 57±15 years and 52 patients were males. The most common etiologies were degenerative disease (73 patients) and rheumatic disease (34 patients). Early mortality was 2.4% and late survival was 84.3% at 10 years, which are similar to the age- and gender-matched general population. Only two patients developed severe mitral regurgitation, and both were reoperated (95.6% at 10 years). Freedom from mitral valve failure was 84.5% at 10 years, with no difference between degenerative and rheumatic valves. Overall, late ≥ moderate tricuspid regurgitation was present in 34% of the patients, being more common in the rheumatic ones. The use of tricuspid annuloplasty abolished this complication. Conclusion We have demonstrated that mitral regurgitation due to organic mitral valve disease from various etiologies can be surgically treated with a high repair rate, low early mortality and long-term survival that are comparable to the matched general population. Concomitant treatment of atrial fibrillation and tricuspid valve may be important adjuncts to optimize long-term results.
              Bookmark

              Author and article information

              Contributors
              Role: Handling Editor
              Role: Editor
              Role: Editor
              Journal
              Eur Heart J Case Rep
              Eur Heart J Case Rep
              ehjcr
              European Heart Journal: Case Reports
              Oxford University Press
              2514-2119
              October 2020
              18 September 2020
              18 September 2020
              : 4
              : 5
              : 1-2
              Affiliations
              Adult Cardiology Department, King Fahad Medical City , Dabab street, Sulaimaniya, PO Box 59046, 11525 Riyadh, Saudi Arabia
              Author notes
              Corresponding author. Tel: 00966539417315, Email: azamshah165@ 123456hotmail.com
              Article
              ytaa345
              10.1093/ehjcr/ytaa345
              7649506
              0c6b75e7-ca37-406f-a5d5-851e32a1e98f
              © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

              This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

              History
              : 09 July 2020
              : 29 July 2020
              : 24 August 2020
              Page count
              Pages: 2
              Categories
              Images Cardio
              Cardiac Imaging (Echocardiography / Cardiac MRI / Nuclear Cardiology
              AcademicSubjects/MED00200

              Comments

              Comment on this article